Venrock Healthcare Capital Partners II, L.P. 13D and 13G filings for Corvus Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2022-02-14 4:15 pm Sale | 2021-12-31 | 13G | Corvus Pharmaceuticals, Inc. CRVS | Venrock Healthcare Capital Partners II, L.P. | 250,000 0.500% | -3,177,461 (-92.71%) | Filing |
| 2021-09-30 4:05 pm Purchase | 2021-09-20 | 13G | Corvus Pharmaceuticals, Inc. CRVS | Venrock Healthcare Capital Partners II, L.P. | 3,427,461 8.100% | 3,427,461 (New Position) | Filing |